Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A xenotropic murine leukemia virus-related virus (XMRV) has recently been reported in association with prostate cancer and chronic fatigue syndrome, with a prevalence of up to 3.7% in the healthy population. We looked for XMRV in 230 patients with human immunodeficiency virus type 1 or hepatitis C infection. XMRV was undetectable in plasma or peripheral blood mononuclear cells by polymerase chain reaction targeting XMRV gag or env. T cell responses to XMRV Gag were undetectable in peripheral blood mononuclear cells by ex vivo gamma interferon enzyme-linked immunospot assay. In our cohorts, XMRV was not enriched in patients with blood-borne or sexually transmitted infections from the United Kingdom and Western Europe.

Original publication




Journal article


J Infect Dis

Publication Date





1482 - 1485


Adult, Aged, Cohort Studies, Enzyme-Linked Immunosorbent Assay, Europe, Female, Gene Products, gag, Genes, Viral, HIV Infections, HIV-1, Hepatitis C, Chronic, Humans, Interferon-gamma, Leukemia Virus, Murine, Leukocytes, Mononuclear, Male, Middle Aged, Polymerase Chain Reaction, Retroviridae Infections, Risk Factors, Tumor Virus Infections, United Kingdom, Viral Envelope Proteins, Young Adult